Endo Int'l (ENDP) Tops Q1 EPS by 11c; Boosts FY15 EPS Outlook

Endo Int'l (NASDAQ: ENDP) reported Q1 EPS of $1.17, $0.11 better than the analyst estimate of $1.06. Revenue for the quarter came in at $714 million versus the consensus estimate of $714.42 million.

Endo Int'l sees FY2015 EPS of $4.40 - $4.60, versus prior guidance of $4.35 - $4.55 and the consensus of $4.48. Endo Int'l sees FY2015 revenue of $2.90 - $3.00 billion, versus the consensus of $2.99 billion.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance